Previous studies have demonstrated the ability of two novel small molecule inhibitors, the IAP inhibitor birinapant and the WEE1 inhibitor AZD1775, to sensitize HNSCC to TNFα dependent cell killing in vitro and radiotherapy in vivo. Here, WEE1 is linked to head and neck squamous cell carcinoma.